Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Breast Cancer × olaparib × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 23 Breast Neoplasms 13 Neoplasms 9 Triple Negative Breast Neoplasms 6 Prostatic Neoplasms 6 Sarcoma 5 Pancreatic Neoplasms 5 Fanconi Anemia, Complementation Group D1 5 Endometrial Neoplasms 5 Small Cell Lung Carcinoma 4 Neoplasm Metastasis 4 Colorectal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Rhabdomyosarcoma 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Metastatic Castration-resistant Prostate Cancer 2 Glioma 2 Central Nervous System Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Solid Tumours 2 Advanced Solid Tumors 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Solid Tumor 1 Smoking 1

Interventions

Fulvestrant 5 Anastrozole 4 Letrozole 2 Docetaxel 2 Dasatinib 2 vandetanib 1 sonidegib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 exemestane 1 cediranib 1 Vorinostat 1 Tablets 1 Population Groups 1 Moxifloxacin 1 Histone Deacetylase Inhibitors 1 FCN-437c 1 Everolimus 1 Electroporation 1 Cryosurgery 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03205761 2024-10-18

COMETABreast

Spanish Breast Cancer Research Group

Phase 2 Completed

11 enrolled 20 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡